Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamasaki, K.
Right arrow Articles by Nojimal, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hamasaki, K.
Right arrow Articles by Nojimal, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 6, No. 9, 734-736 (1997)
DOI: 10.1177/096120339700600910

Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody

K. Hamasaki

The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo

T. Mimura

The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo

H. Kanda

The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo

N. Morino

The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo

Y. Yazaki

The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo

Y. Nojimal

Department of Clinical Immunology and AIDS Research Center, The Institute of Medical Science, University of Tokyo, Tokyo, Japan

We describe a patient with rheumatoid arthritis (RA) whose sera contained a high titre of an antibody targeting cytoplasmic ribosomal P proteins (anti-P). This association preceded by 6 years the development of serological and clinical manifestations of systemic lupus erythematosus (SLE). The clinical significance of anti-P for the diagnosis of SLE is discussed.

Key Words: systemic lupus erythematosus • rheumatoid arthritis • anti-ribosomal P protein antibody


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
J A Simon, J Granados, J Cabiedes, J R. Morales, and J A. Varela
Clinical and immunogenetic characterization of Mexican patients with 'Rhupus'
Lupus, May 1, 2002; 11(5): 287 - 292.
[Abstract] [PDF]


Home page
J. Clin. Pathol.Home page
E C Jury, D D'Cruz, and W J W Morrow
Autoantibodies and overlap syndromes in autoimmune rheumatic disease
J. Clin. Pathol., May 1, 2001; 54(5): 340 - 347.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A Ghirardello, A Doria, S Zampieri, R Gerli, E Rapizzi, and P F Gambari
Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies
Ann Rheum Dis, December 1, 2000; 59(12): 975 - 981.
[Abstract] [Full Text]